DIFFERENT BIOLOGICALLY ACTIVATED SYSTEMS RESISTANCE TO INHIBITION
نویسندگان
چکیده
منابع مشابه
Is Biologically Inspired Invention Different?
The paradigm of biologically inspired design views nature as a vast library of robust, efficient and multifunctional designs, and espouses the use nature as a source of analogues for inspiring novel designs in domains of interest such as architecture, computing, engineering, etc. Over the last generation, biologically inspired design has emerged as a major movement in engineering, architectural...
متن کاملDemystify False Dilemmas to Speak About Corruption in Health Systems: Different Actors, Different Perspectives, Different Strategies; Comment on “We Need to Talk About Corruption in Health Systems”
The call of the editorial of the International Journal of Health Policy and Management regarding the “Need to talk about corruption in health systems” is spot on. However, the perceived difficulties of why this is so should be explored from an actor’s perspective, as they differ for government actors, donors and the research community. In particular, false dilemmas around definition pr...
متن کاملA Comparison of Static to Biologically Modeled Intrusion Detection Systems
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Chapter
متن کاملBiologically-inspired Complex Adaptive Systems approaches to Network Intrusion Detection
The pervasiveness of the computing power has made it an inevitable commodity of the modern time. The inexorable technological advances clearly predict the continually increasing reliance of human life on the computing systems in the future. Intelligent portable devices are commonplace these days and information accessibility is ubiquitous. There is a network underlying any computer infrastructu...
متن کاملIntrinsic resistance to JAK2 inhibition in myelofibrosis.
PURPOSE Recent results have shown that myeloproliferative neoplasms (MPN) are strongly associated with constitutive activation of the Janus-activated kinase (JAK)2 tyrosine kinase. However, JAK2 inhibitors currently approved or under development for treating myeloproliferative neoplasms do not selectively deplete the malignant clone, and the inhibition of activity of the drug target (JAK2) has ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Environment. Technology. Resources. Proceedings of the International Scientific and Practical Conference
سال: 2005
ISSN: 2256-070X,1691-5402
DOI: 10.17770/etr2005vol1.2152